公司資料
ContraFect Corporation 股價、新聞與催化劑
- 股票代碼:
- CFRX
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股價為何變動
目前無法取得 CFRX 的收盤價變動背景。
公司概覽
業務概覽
ContraFect Corporation was a biotechnology company focused on anti-infective proteins and pathogen-targeting therapies before becoming a legacy ticker. Its story was centered on using biologic mechanisms to address difficult infectious diseases.
所在地與產業分類
ContraFect was headquartered in the United States and listed on NASDAQ. It sat in small-cap anti-infective biotechnology.
商業模式特徵
The company depended on clinical validation, capital support, and the ability to advance a narrow infectious-disease pipeline. Investors historically watched data and financing runway.
生技產業定位
ContraFect belongs to the historical anti-infective biotech bucket. It was a catalyst-sensitive name where program progress and capital were always central.
未來催化劑
- ContraFect is a legacy / closeout story, so the catalysts are any remaining strategic or asset-resolution update rather than a live anti-infective milestone. The market is focused on residual value.
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。